Bioelectronics Corp (BIEL)

[DewmBoom]

$BIEL: This stock is my No. 1 pick for 2018, with a target price north of 0.01.

The recent UK National Health Service News is the result of two years of hardwork and waiting for this approval. This will allow physicians to prescribe the Actipatch for patients with full reimbursement by the NHS. Over 50 million british citizens may benefit from this accomplishement.

The low back pain clincial trial was completed as of December 21, 2017, and news about that is imminent. This is the final ticket for full FDA clearance of the Actipatch for over the counter sale for general use. Note that Biel has already two approvals by the FDA on the Actipatch for knee and foot pain, but the low back pain clincal trial will give it full clearance to be sold over the counter for the treatment of Chronic Musculoskeletal pain in the fight against opioids. The knee and foot Actipatch is currently available at amazon https://www.amazon.com/s/ref=nb_sb_noss_2?url=search-alias%3Dhpc&field-keywords=actipatch

Another clincial trial on Migraine is due to be completed by January 21, 2018.

USA distribution is ready to go with the recent distributor ANDA, a subidiary of TEVA. https://www.andanet.com/login.htm .

Do your DD by reading the following References:

https://finance.yahoo.com/news/bioelectronics-actipatch-drug-free-pain-120000840.html

https://finance.yahoo.com/news/bioelectronics-announces-actipatch-over-counter-133000882.html

https://clinicaltrials.gov/ct2/show/NCT03240146

https://clinicaltrials.gov/ct2/show/NCT03166046

http://www.bielcorp.com/